Teriflunomide is an oral monotherapy for the treatment of patients with relapsing remitting multiple sclerosis (RRMS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability. The oral therapy allow an easy compliance by the patients, differently from other injectable products utilizided in the RRMS.

Carfilzomib is approved for the treatment of multiple myleoma, a plasma cell cancer, often used in combination with other medicines with a similar therapeutic effect. It is used to treat patients with relapsed or refractory multiple myeloma who have received previous treatments.

Fenfluramine is indicated for the treatment of seizures associated with Dravet syndrome and Lennox Gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients of 2 years of age and older. Fenfluramine is a phenethylamine that is structurally similar to serotonin.

Maribavir is an antiviral drug for treating cytomegalovirus (CMV) in adults who have had a stem cell or organ transplant and did not respond to prior treatments. CMV is a common virus that remains dormant but can reactivate in immunocompromised patients, causing illness.